The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)

<p>Abstract</p> <p>A mixed hidden Markov model (HMM) was developed for predicting breeding values of a biomarker (here, somatic cell score) and the individual probabilities of health and disease (here, mastitis) based upon the measurements of the biomarker. At a first level, the un...

Full description

Bibliographic Details
Main Author: Detilleux Johann C
Format: Article
Language:deu
Published: BMC 2008-09-01
Series:Genetics Selection Evolution
Subjects:
Online Access:http://www.gsejournal.org/content/40/5/491
id doaj-3b44301c43aa4dc0aecaed012b8e2132
record_format Article
spelling doaj-3b44301c43aa4dc0aecaed012b8e21322020-11-24T22:18:12ZdeuBMCGenetics Selection Evolution0999-193X1297-96862008-09-0140549150910.1186/1297-9686-40-5-491The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)Detilleux Johann C<p>Abstract</p> <p>A mixed hidden Markov model (HMM) was developed for predicting breeding values of a biomarker (here, somatic cell score) and the individual probabilities of health and disease (here, mastitis) based upon the measurements of the biomarker. At a first level, the unobserved disease process (Markov model) was introduced and at a second level, the measurement process was modeled, making the link between the unobserved disease states and the observed biomarker values. This hierarchical formulation allows joint estimation of the parameters of both processes. The flexibility of this approach is illustrated on the simulated data. Firstly, lactation curves for the biomarker were generated based upon published parameters (mean, variance, and probabilities of infection) for cows with known clinical conditions (health or mastitis due to <it>Escherichia coli </it>or <it>Staphylococcus aureus</it>). Next, estimation of the parameters was performed <it>via </it>Gibbs sampling, assuming the health status was unknown. Results from the simulations and mathematics show that the mixed HMM is appropriate to estimate the quantities of interest although the accuracy of the estimates is moderate when the prevalence of the disease is low. The paper ends with some indications for further developments of the methodology.</p> http://www.gsejournal.org/content/40/5/491hidden Markov modelmixed modelmastitissomatic cell score
collection DOAJ
language deu
format Article
sources DOAJ
author Detilleux Johann C
spellingShingle Detilleux Johann C
The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)
Genetics Selection Evolution
hidden Markov model
mixed model
mastitis
somatic cell score
author_facet Detilleux Johann C
author_sort Detilleux Johann C
title The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)
title_short The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)
title_full The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)
title_fullStr The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)
title_full_unstemmed The analysis of disease biomarker data using a mixed hidden Markov model (<it>Open Access publication</it>)
title_sort analysis of disease biomarker data using a mixed hidden markov model (<it>open access publication</it>)
publisher BMC
series Genetics Selection Evolution
issn 0999-193X
1297-9686
publishDate 2008-09-01
description <p>Abstract</p> <p>A mixed hidden Markov model (HMM) was developed for predicting breeding values of a biomarker (here, somatic cell score) and the individual probabilities of health and disease (here, mastitis) based upon the measurements of the biomarker. At a first level, the unobserved disease process (Markov model) was introduced and at a second level, the measurement process was modeled, making the link between the unobserved disease states and the observed biomarker values. This hierarchical formulation allows joint estimation of the parameters of both processes. The flexibility of this approach is illustrated on the simulated data. Firstly, lactation curves for the biomarker were generated based upon published parameters (mean, variance, and probabilities of infection) for cows with known clinical conditions (health or mastitis due to <it>Escherichia coli </it>or <it>Staphylococcus aureus</it>). Next, estimation of the parameters was performed <it>via </it>Gibbs sampling, assuming the health status was unknown. Results from the simulations and mathematics show that the mixed HMM is appropriate to estimate the quantities of interest although the accuracy of the estimates is moderate when the prevalence of the disease is low. The paper ends with some indications for further developments of the methodology.</p>
topic hidden Markov model
mixed model
mastitis
somatic cell score
url http://www.gsejournal.org/content/40/5/491
work_keys_str_mv AT detilleuxjohannc theanalysisofdiseasebiomarkerdatausingamixedhiddenmarkovmodelitopenaccesspublicationit
AT detilleuxjohannc analysisofdiseasebiomarkerdatausingamixedhiddenmarkovmodelitopenaccesspublicationit
_version_ 1725782857097412608